Ali Alhuseinalkhudhur
Postdoctoral position at Department of Immunology, Genetics and Pathology; Research programme: Cancer Precision Medicine; Research group Vladimir Tolmachev
- E-mail:
- ali.alkhudhur@igp.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postal address:
- Rudbecklaboratoriet
751 85 UPPSALA
Publications
Recent publications
-
Part of Cancers, 2026
- DOI for Predicting Therapeutic Response to Antibody-Drug Conjugates Using Targeted PET Imaging: A Systematic Review
- Download full text (pdf) of Predicting Therapeutic Response to Antibody-Drug Conjugates Using Targeted PET Imaging: A Systematic Review
-
Part of Journal of Clinical Oncology, 2024
-
Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy
Part of Biomedicines, 2024
- DOI for Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy
- Download full text (pdf) of Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy
-
HER2-receptor quantification in breast cancer patients by imaging with ABY-025 Affibody and PET
2024
-
Part of Journal of Nuclear Medicine, p. 1364-1370, 2023
- DOI for Human Epidermal Growth Factor Receptor 2-Targeting [68Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer.
- Download full text (pdf) of Human Epidermal Growth Factor Receptor 2-Targeting [68Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer.
All publications
Articles in journal
-
Part of Journal of Clinical Oncology, 2024
-
Part of Journal of Nuclear Medicine, p. 1364-1370, 2023
- DOI for Human Epidermal Growth Factor Receptor 2-Targeting [68Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer.
- Download full text (pdf) of Human Epidermal Growth Factor Receptor 2-Targeting [68Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer.
-
Part of EJNMMI Research, 2020
- DOI for Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer
- Download full text (pdf) of Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer
-
Part of Theranostics, p. 3476-3484, 2019
- DOI for Regularized reconstruction of digital time-of-flight Ga-68-PSMA-11 PET/CT for the detection of recurrent disease in prostate cancer patients
- Download full text (pdf) of Regularized reconstruction of digital time-of-flight Ga-68-PSMA-11 PET/CT for the detection of recurrent disease in prostate cancer patients
-
Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 569-579, 2019
-
Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018
Articles, review/survey
-
Part of Cancers, 2026
- DOI for Predicting Therapeutic Response to Antibody-Drug Conjugates Using Targeted PET Imaging: A Systematic Review
- Download full text (pdf) of Predicting Therapeutic Response to Antibody-Drug Conjugates Using Targeted PET Imaging: A Systematic Review
-
Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy
Part of Biomedicines, 2024
- DOI for Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy
- Download full text (pdf) of Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy